The Quarterly Update for Clinical Laboratory Fee Schedule (CLFS) and Laboratory Services Subject to Reasonable Charge Payment contains a new series of PLA codes that are effective July 1, 2024. The following table contains the codes and long descriptors. Notify your staff of these updates. For a full list of the codes and other info on the Update, please review the transmittal link.
| CPT Code | Long Descriptor | TOS |
| 0450U | Oncology (multiple myeloma), liquid chromatography with tandem mass spectrometry (LCMS/MS), monoclonal paraprotein sequencing analysis, serum, results reported as baseline presence or absence of detectable clonotypic peptides | 5 |
| 0451U | Oncology (multiple myeloma), LCMS/MS, peptide ion quantification, serum, results compared with baseline to determine monoclonal paraprotein abundanc | 5 |
| 0452U | Oncology (bladder), methylated PENK DNA detection by linear target enrichment-quantitative methylationspecific real-time PCR (LTE-qMSP), urine, reported as likelihood of bladder cancer | 5 |
| 0453U | Oncology (colorectal cancer), cellfree DNA (cfDNA), methylationbased quantitative PCR assay (SEPTIN9, IKZF1, BCAT1, Septin9-2, VAV3, BCAN), plasma, reported as presence or absence of circulating tumor DNA (ctDNA) | 5 |
| 0454U | Rare diseases (constitutional/heritable disorders), identification of copy number variations, inversions, insertions, translocations, and other structural variants by optical genome mapping | 5 |
| 0455U | Infectious agents (sexually transmitted infection), Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis, multiplex amplified probe technique, vaginal, endocervical, gynecological specimens, oropharyngeal swabs, rectal swabs, female or male urine, each pathogen reported as detected or not detected | 5 |
| 0456U | Autoimmune (rheumatoid arthritis), next-generation sequencing (NGS), gene expression testing of 19 genes, whole blood, with analysis of anticyclic citrullinated peptides (CCP) levels, combined with sex, patient global assessment, and body mass index (BMI), algorithm reported as a score that predicts nonresponse to tumor necrosis factor inhibitor (TNFi) therapy | 5 |
| 0457U | Perfluoroalkyl substances (PFAS) (eg, perfluorooctanoic acid, perfluorooctane sulfonic acid), 9 PFAS compounds by LC-MS/MS, plasma or serum, quantitative | 5 |
| 0458U | Oncology (breast cancer), S100A8 and S100A9, by enzymelinked immunosorbent assay (ELISA), tear fluid with age, algorithm reported as a risk score | 5 4 |
| 0459U | β-amyloid (Abeta42) and total tau (tTau), electrochemiluminescent immunoassay (ECLIA), cerebral spinal fluid, ratio reported as positive or negative for amyloid pathology | 5 |
Stay ahead of regulatory changes with the “2024 Lab Regulatory Update: Preparing for the Future.” This comprehensive resource is designed to equip your lab with the latest compliance strategies and insights. Don’t let new regulations catch you off guard—ensure your lab’s readiness and compliance today. Learn more and secure your copy to stay informed and prepared.
Maximize your earnings in the remaining 6 months of 2024 by seizing our 2024 close-out opportunity and securing your financial future with our Coding Essentials for Laboratories. Order your resource today and enjoy 50% savings while enhancing your coding and billing expertise. This exclusive offer is valid until July 5th, and inventory is limited.
To receive your 50% discount, use the code CO5024 at checkout on our web store.
Act now before this exclusive offer expires on July 5th!
Information Source:
https://www.cms.gov/files/document/r12657cp.pdf
When it comes to coding for complex interventional radiology procedures like endoleak embolization, the stakes are high. Inaccurate coding not only threatens compliance and reimbursement
The new year rang in with a heavy storm of new coding changes for laboratory and pathology coding. The first half of the year is
Please log in to your account to comment on this article.
Subscribe to receive our News, Insights, and Compliance Question of the Week articles delivered right to your inbox.
Subscribe to receive our News, Insights, and Compliance Question of the Week delivered right to your inbox.
Address: 5874 Blackshire Path, #13, Inver Grove Heights, MN 55076
Phone: (800) 252-1578
Email: support@medlearnmedia.com
Hours: 9am – 5pm CT
Copyright © 2025 MedLearn Publishing. Powered by MedLearn Media.
Celebrate Lab Week with MedLearn! Sign up to win one year of our Laboratory All Access Pass! Click here to learn more →
Unlock 50% off all 2024 edition books when you order by July 5! Use the coupon code CO5024 at checkout to claim this offer!
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24
